f 3

Ginsenoside-F3 has immunoenhancing activity by regulating production and gene expression of type 1, type 2 cytokines in murine spleen cells. Ginsenoside-F3 enhances the NF-kappaB DNA binding activity induced by ConA in murine spleen cells (10 μM).

F3-PEG8-RiboTAC is a RiboTAC compound that specifically degrades the mRNA of the oncogene LGALS1. This compound can induce apoptosis (cell death) in tumor cells and inhibit their invasion. F3-PEG8-RiboTAC exhibits antitumor activity and is applicable in research on leukemia and triple-negative breast cancer. (RNase L ligand; RNA binder; Linker)

Anti-F3/Factor III/Tissue Factor/CD142 Antibody represents a highly specialized monoclonal antibody specifically engineered to target the human Tissue Factor (TF/CD142) with exceptional binding affinity. It effectively facilitates the measurable targeting of TF-expressing malignant cells across various preclinical experimental models to evaluate the delivery of cytotoxic payloads or the disruption of TF-mediated oncogenic signaling during strictly monitored laboratory observation periods and functional cell viability assays without compromising systemic coagulation homeostasis.

DSPE-PEG5000-F3 consists of DSPE and the nucleolin-targeting peptide (F3) and is a PEGylated compound. The F3 peptide specifically binds to nucleolin on the cell surface, facilitating efficient transport from the cell surface to the nucleus. DSPE-PEG5000-F3 is applicable for drug delivery.

DSPE-PEG1000-F3 is a PEG compound made from DSPE and a targeting peptide called nucleolin (F3). The F3 peptide can specifically bind to cell surface nucleolin, enabling efficient transport from the cell surface to the nucleus. DSPE-PEG1000-F3 is applicable in drug delivery.

DSPE-PEG2000-F3 is a PEG compound composed of DSPE and the nucleolin-targeting peptide (F3). The F3 peptide can specifically bind to nucleolin on the cell surface, facilitating efficient transport from the cell surface to the nucleus. DSPE-PEG2000-F3 is applicable for drug delivery.

DSPE-PEG3400-F3 is a PEG-modified compound composed of DSPE and the nucleolin-targeting peptide (F3). The F3 peptide has the ability to specifically bind to cell surface nucleolin and facilitate efficient transport from the cell surface to the nucleus. DSPE-PEG3400-F3 is applicable in drug delivery.

Ginsenoside F3 (Standard) is a reference standard for research and analysis in studies involving Ginsenoside F3. Ginsenoside-F3 has immunoenhancing activity by regulating production and gene expression of type 1, type 2 cytokines in murine spleen cells. Ginsenoside-F3 enhances the NF-kappaB DNA binding activity induced by ConA in murine spleen cells (10 μM).

F3 peptide is a fragment of human high mobility group protein 2 (HMGB2) that specifically binds to nucleolin, expressed on the membranes of cancer cells, neovasculature, and endothelial cells. Serving as an effective ligand, F3 peptide enhances the druggability of macromolecular drugs or nanoparticles.

Osimertinib (AZD-9291) is an EGFR third-generation inhibitor that inhibits the T790M resistance mutation produced by second-generation EGFR inhibitors with irreversible and oral activity. Osimertinib has antitumor activity for the treatment of EGFR-mutated non-small-cell lung cancer.

Osimertinib mesylate (AZD-9291 mesylate) is an EGFR third-generation inhibitor that inhibits the T790M resistance mutation produced by second-generation EGFR inhibitors with irreversible and oral activity. Osimertinib mesylate has antitumor activity for the treatment of EGFR-mutated non-small-cell lung cancer.

Calcium glycerophosphate(CaGP) is an inhibitor of intestinal alkaline phosphatase F3. Calcium glycerophosphate can be a source of calcium and phosphorus in total parenteral nutrition solutions [1] [2].

GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl.

3'-F-3'-dA(Bz)-2'-phosphoramidite is a fluoro-modified nucleoside derivative used as a nucleoside phosphoramidite.

3'-F-3'-dG(iBu)-2'-phosphoramidite is a Nucleoside Phosphoramidite.

Prostaglandin F3α (PGF3α) is a bioactive lipid mediator derived from eicosapentaenoic acid (EPA) with anticancer and anti-inflammatory properties. It serves as a substrate for ABCC4 with a Km of 12.1 μM. Additionally, Prostaglandin F3α (PGF3α) is utilized in diabetes research.

8-iso PGF3α is an isoprostane produced from the free-radical peroxidation of EPA. While little is known about its biological activity, one report indicates it is inactive in a TP receptor-mediated assay of human platelet shape change, a test in which 8-iso PGF2α has an ED50 value of 1 uM. [1]

Tuxobertinib (BDTX-189) is a potent and selective inhibitor of allosteric EGFR and HER2 oncogenic mutations, with KDs of 0.2, 0.76, 13, and 1.2 nM for EGFR, HER2, BLK, and RIPK2, respectively, and exhibits anticancer activity.

Anti-Mouse IL-17A Antibody (17F3) is a mouse-derived IgG1, κ antibody inhibitor that targets mouse IL-17A.

Anti-Mouse IL-6 Antibody (MP5-20F3) is a monoclonal antibody against mouse IL-6, which can reshape the tumor microenvironment by blocking IL-6, inhibit the STAT3 pathway and enhance T cell infiltration, and is suitable for research on inflammatory and infectious diseases (such as malignant pleural effusion, MPE).

Anti-MouseVISTAAntibody (13F3) is an IgG antibody inhibitor originating from American hamsters and targeting mouse VISTA.

(17E)-Prostaglandin F3α (17-trans-PGF3α) is a double bond isomer of Prostaglandin F3α and is a potential metabolite of trans dietary fatty acids. This compound exhibits anti-inflammatory properties.

3F8 is a selective GSK-3β inhibitor that can be used as a new tool and potential therapeutic candidate compound for GSK3-related diseases, and can be used in the study of neurological disorders and cancer.

3-O-Methyltagitinin F is a useful organic compound for research related to life sciences and the catalog number is T126402.